CY2399B1 - Pharmaceutical composition containing cyclosporin derivative. - Google Patents

Pharmaceutical composition containing cyclosporin derivative.

Info

Publication number
CY2399B1
CY2399B1 CY0300096A CY0300096A CY2399B1 CY 2399 B1 CY2399 B1 CY 2399B1 CY 0300096 A CY0300096 A CY 0300096A CY 0300096 A CY0300096 A CY 0300096A CY 2399 B1 CY2399 B1 CY 2399B1
Authority
CY
Cyprus
Prior art keywords
pharmaceutical composition
composition containing
containing cyclosporin
cyclosporin derivative
composition
Prior art date
Application number
CY0300096A
Other languages
English (en)
Inventor
Armin Meinzer
Friedrich Richter
Jacky Francis Vonderscher
Original Assignee
Sandoz Ltd
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd, Sandoz Ag filed Critical Sandoz Ltd
Publication of CY2399B1 publication Critical patent/CY2399B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
CY0300096A 1992-04-22 2003-12-31 Pharmaceutical composition containing cyclosporin derivative. CY2399B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929208712A GB9208712D0 (en) 1992-04-22 1992-04-22 Pharmaceutical compositions containing cyclosporin derivates

Publications (1)

Publication Number Publication Date
CY2399B1 true CY2399B1 (en) 2004-09-10

Family

ID=10714386

Family Applications (1)

Application Number Title Priority Date Filing Date
CY0300096A CY2399B1 (en) 1992-04-22 2003-12-31 Pharmaceutical composition containing cyclosporin derivative.

Country Status (22)

Country Link
EP (1) EP0637248B1 (el)
JP (1) JP2818298B2 (el)
KR (2) KR950701227A (el)
AT (1) ATE219940T1 (el)
AU (1) AU672793B2 (el)
CA (1) CA2132740C (el)
CY (1) CY2399B1 (el)
CZ (1) CZ287359B6 (el)
DE (1) DE69332078T2 (el)
DK (1) DK0637248T3 (el)
ES (1) ES2179052T3 (el)
FI (1) FI111130B (el)
GB (1) GB9208712D0 (el)
HU (1) HU218279B (el)
NO (1) NO315075B1 (el)
NZ (1) NZ252681A (el)
PT (1) PT637248E (el)
RU (1) RU2126263C1 (el)
SG (1) SG50692A1 (el)
SK (1) SK282745B6 (el)
UA (1) UA34454C2 (el)
WO (1) WO1993020833A1 (el)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
JP3631490B2 (ja) 1992-05-13 2005-03-23 ノバルティス ファーマ株式会社 シクロスポリン含有眼科用組成物
EP0589843B1 (en) * 1992-09-25 2001-11-28 Novartis AG Pharmaceutical compositions containing cyclosporins
GB2278780B (en) * 1993-05-27 1998-10-14 Sandoz Ltd Macrolide formulations
CH686761A5 (de) 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
GB2315216B (en) * 1993-10-05 1998-10-14 Ciba Geigy Ag Microemulsion preconcentrates comprising FK506 or 33-epi-chloro-33-desoxy-ascomycin
RU2158601C2 (ru) 1994-11-03 2000-11-10 Новартис Аг Новые лекарственные формы циклоспорина для орального применения с простым составом и высокой биодоступностью и способ их получения
HU215966B (hu) * 1994-11-21 1999-07-28 BIOGAL Gyógyszergyár Rt. Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US5766629A (en) 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
DE19549852B4 (de) 1995-11-29 2009-06-04 Novartis Ag Cyclosporin enthaltende Präparate
GB9601120D0 (en) * 1996-01-19 1996-03-20 Sandoz Ltd Organic compounds
DK0989851T3 (da) * 1997-07-29 2003-01-27 Upjohn Co Selvemulgerende formulering indeholdende sure lipofile forbindelser
ES2219895T3 (es) * 1997-07-29 2004-12-01 PHARMACIA & UPJOHN COMPANY Formulacion autoemulsionante para compuestos lipofilos.
US6346511B1 (en) 1997-09-08 2002-02-12 Panacea Biotec Limited Pharmaceutical composition comprising cyclosporin
US6008191A (en) * 1997-09-08 1999-12-28 Panacea Biotec Limited Pharmaceutical compositions containing cyclosporin
US6187747B1 (en) 1997-09-08 2001-02-13 Panacea Biotech Limited Pharmaceutical composition comprising cyclosporin
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
BR0210505A (pt) 2001-06-21 2004-05-18 Pfizer Prod Inc Formulações auto-emulsionantes de inibidores da proteìna de transferência de ésteres de colesterilo
US6828301B2 (en) 2002-02-07 2004-12-07 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for hepatitis C viral protease inhibitors
EP2204167A1 (en) * 2009-01-05 2010-07-07 Azad Pharma AG Pharmaceutical microemulsion for preventing supramolecular aggregation of amphiphilic molecules
PT2451438E (pt) 2009-07-07 2014-03-26 Boehringer Ingelheim Int Composição farmacêutica para um inibidor de protease viral da hepatite c

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI65914C (fi) * 1978-03-07 1984-08-10 Sandoz Ag Foerfarande foer framstaellning av farmaceutiska kompositionerinnehaollande cyklosporin a
EP0296122B1 (en) * 1987-06-17 1993-09-29 Sandoz Ag Cyclosporins and their use as pharmaceuticals
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물

Also Published As

Publication number Publication date
AU4261193A (en) 1993-11-18
FI944978A0 (fi) 1994-10-21
KR950701227A (ko) 1995-03-23
UA34454C2 (uk) 2001-03-15
RU2126263C1 (ru) 1999-02-20
FI111130B (fi) 2003-06-13
DE69332078D1 (de) 2002-08-08
NO943998D0 (no) 1994-10-21
NZ252681A (en) 1996-02-27
CZ287359B6 (en) 2000-11-15
EP0637248A1 (en) 1995-02-08
PT637248E (pt) 2002-11-29
WO1993020833A1 (en) 1993-10-28
CA2132740A1 (en) 1993-10-28
ES2179052T3 (es) 2003-01-16
GB9208712D0 (en) 1992-06-10
CZ261794A3 (en) 1995-02-15
EP0637248B1 (en) 2002-07-03
SG50692A1 (en) 1999-05-25
RU94046413A (ru) 1996-11-10
FI944978A (fi) 1994-10-21
KR100414853B1 (el) 2004-01-13
AU672793B2 (en) 1996-10-17
HU218279B (en) 2000-07-28
JP2818298B2 (ja) 1998-10-30
SK282745B6 (sk) 2002-12-03
HU9403055D0 (en) 1994-12-28
NO943998L (no) 1994-10-21
HUT71580A (en) 1995-12-28
NO315075B1 (no) 2003-07-07
SK127294A3 (en) 1995-04-12
ATE219940T1 (de) 2002-07-15
DK0637248T3 (da) 2002-10-28
CA2132740C (en) 2008-01-15
DE69332078T2 (de) 2002-12-19
JPH07505872A (ja) 1995-06-29

Similar Documents

Publication Publication Date Title
SG50692A1 (en) Pharmaceutical composition containing cyclosporin derivative
ES2098180A1 (es) Una composicion farmaceutica a base de compuestos de la clase de la rapamicina.
CA2099782A1 (fr) Derive de la 5h-pyrrolo[3,4-b] pyrazine optiquement actif, sa preparation et les compositions pharmaceutiques qui le contiennent
CA2189351A1 (en) Narcotic containing aerosol formulation
EP0573423A4 (en) Methods and preparations of stable, deodorized oils and pharmaceutical compositions thereof
CA2193337A1 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
HUT75470A (en) Lipophilic carrier preparations
AU629669B2 (en) Diarylacetylenes, the preparations and use thereof
IL102633A0 (en) Compositions
DE69700317T2 (de) Mikrotröpfchen-Arzneizubereitungen enthaltend Propofol
CA2067754A1 (en) Preparation for the application of agents in mini-droplets
YU3700A (sh) Farmaceutske kompozicije koje sadrže vitamin d i kalcijum, njihovo dobijanje i upotreba
HUP9900365A2 (hu) N-Aril-1,2,4-triazolin-5-on-származékok, előállításuk és alkalmazásuk, a vegyületeket hatóanyagként tartalmazó inszekticid, arachnicid és nematocid készítmények
IL105942A0 (en) Biologically active eburnamenine derivatives,their preparation and pharmaceutical compositions containing them
AU7588094A (en) Dihalopropene compound, insecticide/acaricide containing said diahalopropene compound as active ingredient, and intermediate compound for use in production of said dihalopropene compound
KR950007857A (ko) 경구투여용 라파마이신 제제
NO175826C (no) Mikrobiologisk fremgangsmåte ved fremstilling av agrarkjemisk anvendelige virkestoffer, fremstilte forbindelser, anvendelsen av disse og biologisk rene kulturer av sorangium cellulosum som anvendes i fremgangsmåten
PL307238A1 (en) Derivatives of ng-monomethyl-l-arginin hydrochloride and their application in treating septic shocks
AU4132693A (en) Substituted 1,2,4-triazine-3,5-dione derivative and anticoccidial drug composition containing the same as active component
AU8079891A (en) Bile alcohol and drug containing the same as active ingredient
IL93721A0 (en) Mixed micelles compositions and their use as carriers for the parenteral application of the drugs
AU2309288A (en) Oxime derivatives and herbicides containing same as active ingredients
AU4965493A (en) Optically active ureido-acetamide derivative, its preparation and drugs containing same